tiprankstipranks
Trending News
More News >
Christie Group plc (GB:CTG)
:CTG
Advertisement

Christie (CTG) AI Stock Analysis

Compare
2 Followers

Top Page

GB:CTG

Christie

(LSE:CTG)

Select Model
Select Model
Select Model
Neutral 54 (OpenAI - 4o)
Rating:54Neutral
Price Target:
99.00p
▼(-10.00% Downside)
Christie's overall stock score reflects a mixed financial performance with signs of recovery but ongoing challenges in revenue stability and leverage. The technical analysis indicates bearish momentum, with the stock being oversold, which could present a buying opportunity if fundamentals improve. Valuation metrics are favorable, with a low P/E ratio and a decent dividend yield, enhancing its attractiveness for value and income investors.

Christie (CTG) vs. iShares MSCI United Kingdom ETF (EWC)

Christie Business Overview & Revenue Model

Company DescriptionChristie (CTG) is a global leader in visual display technologies and solutions, specializing in advanced projection and display systems for various sectors including entertainment, education, healthcare, and corporate environments. The company offers a wide range of products such as projectors, digital signage, and visualization systems that enhance the customer experience and facilitate effective communication. With a strong focus on innovation, Christie provides integrated solutions that cater to the unique needs of its clients, ensuring high-quality visual experiences.
How the Company Makes MoneyChristie generates revenue through multiple streams, primarily by selling its range of visual display products and solutions. This includes direct sales of projectors, display systems, and digital signage to businesses and institutions across various sectors. Additionally, the company earns money from service contracts, maintenance, and support services for its products. Strategic partnerships with technology providers and distributors enhance its market reach and enable Christie to tap into new customer segments. Furthermore, Christie invests in research and development to innovate and expand its product offerings, which helps drive sales and revenue growth.

Christie Financial Statement Overview

Summary
Christie shows signs of financial recovery with improvements in profitability metrics and cash flow generation. However, the company faces challenges with revenue volatility and high leverage, which threaten financial stability. The company has made strides in improving its operational efficiency and capital structure, but maintaining consistent growth and profitability will be key to strengthening its financial position further.
Income Statement
48
Neutral
The income statement shows mixed results. Gross profit margin improved to 3.3% in 2024 from -18% in 2020, indicating better cost management. However, the net profit margin remains volatile, moving from a negative margin in 2023 to a modest 0.89% in 2024, reflecting inconsistent profitability. Revenue growth has been inconsistent, with a notable decline in revenues in 2024 by 8.3% compared to 2023. EBIT and EBITDA margins turned positive in 2024, marking a recovery from negative margins in 2023, but past volatility poses a concern.
Balance Sheet
55
Neutral
The balance sheet shows a moderate improvement in financial stability. The debt-to-equity ratio improved significantly, with equity turning positive in recent years, but remains high due to substantial debt levels. Return on equity was 10.5% in 2024, indicating efficiency in using shareholders' equity, although still below optimal levels. The equity ratio improved to 17.3% in 2024, reflecting better capitalization, but the high total liabilities still pose a risk.
Cash Flow
60
Neutral
Cash flow analysis reveals positive trends, with operating cash flow turning positive in 2024 after a negative period in 2023. Free cash flow has also improved, leading to a positive free cash flow to net income ratio, which suggests better cash generation relative to net income. However, fluctuations in free cash flow growth rates over the years indicate potential instability in cash generation.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue59.85M60.39M52.34M69.19M61.25M42.22M
Gross Profit3.91M2.00M14.77M5.22M2.58M-12.42M
EBITDA5.74M3.94M-1.25M7.25M6.94M-2.81M
Net Income2.12M536.00K-3.80M3.21M3.58M-5.06M
Balance Sheet
Total Assets29.72M29.51M29.45M36.44M36.94M39.77M
Cash, Cash Equivalents and Short-Term Investments4.96M4.87M1.34M8.84M8.17M10.28M
Total Debt8.52M8.71M10.34M11.65M12.23M15.50M
Total Liabilities24.79M24.40M26.15M28.04M35.38M51.16M
Stockholders Equity4.93M5.11M3.30M8.40M1.56M-11.39M
Cash Flow
Free Cash Flow5.40M2.23M-4.38M4.39M1.80M146.00K
Operating Cash Flow5.91M2.73M-3.46M5.18M2.34M1.23M
Investing Cash Flow2.54M2.55M-797.00K-787.00K-487.00K-1.07M
Financing Cash Flow-2.54M-1.66M-3.32M-3.71M-3.21M2.79M

Christie Technical Analysis

Technical Analysis Sentiment
Negative
Last Price110.00
Price Trends
50DMA
109.52
Negative
100DMA
109.92
Negative
200DMA
110.25
Negative
Market Momentum
MACD
-2.03
Negative
RSI
37.92
Neutral
STOCH
46.81
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:CTG, the sentiment is Negative. The current price of 110 is above the 20-day moving average (MA) of 104.13, above the 50-day MA of 109.52, and below the 200-day MA of 110.25, indicating a bearish trend. The MACD of -2.03 indicates Negative momentum. The RSI at 37.92 is Neutral, neither overbought nor oversold. The STOCH value of 46.81 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:CTG.

Christie Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
67
Neutral
£7.04M16.5815.40%6.46%-32.89%
65
Neutral
£12.57M11.5211.18%6.00%110.08%1105.56%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
63
Neutral
£18.55M22.353.15%2.11%-1.00%7.35%
56
Neutral
£13.00M-36.67-3.75%6.90%-242.86%
54
Neutral
£26.10M12.4174.66%2.44%-12.04%
42
Neutral
£14.55M-1.77-106.45%-14.04%24.84%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:CTG
Christie
102.50
-0.58
-0.56%
GB:CEPS
CEPS plc
33.50
10.50
45.65%
GB:REAT
REACT Group plc
55.00
-37.50
-40.54%
GB:VNET
Vianet Group plc
61.00
-40.13
-39.68%
GB:MIND
Mind Gym
14.50
-4.50
-23.68%
GB:DSW
DSW Capital Plc
50.00
-15.67
-23.86%

Christie Corporate Events

Business Operations and Strategy
Christie Group Highlights Resilient Market Conditions in Key Sectors
Positive
Oct 8, 2025

Christie Group plc’s agency and advisory business, Christie & Co, has published its Mid Year Reviews for 2025, highlighting strong market conditions and confidence in the Care, Dental, and Pharmacy sectors. These reviews demonstrate the company’s expertise and involvement in numerous transactions, underscoring a resilient investor and funding environment. This announcement reinforces Christie Group’s strong industry positioning and its commitment to providing in-depth market insights to its clients.

The most recent analyst rating on (GB:CTG) stock is a Hold with a £111.00 price target. To see the full list of analyst forecasts on Christie stock, see the GB:CTG Stock Forecast page.

DividendsFinancial Disclosures
Christie Group Reports Strong H1 2025 Performance with 24% Revenue Growth
Positive
Sep 29, 2025

Christie Group PLC reported a significantly improved financial performance for the first half of 2025, with revenues rising by 24% to £34.8 million and a return to operating profit of £1.3 million. The Professional & Financial Services division saw a 29% revenue increase, contributing to the company’s strengthened cash position and increased interim dividend. The company anticipates continued strong performance in the second half, with robust pipelines in its transactional and advisory businesses, despite some macroeconomic uncertainties.

The most recent analyst rating on (GB:CTG) stock is a Hold with a £110.00 price target. To see the full list of analyst forecasts on Christie stock, see the GB:CTG Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 06, 2025